MONZA, Italy – Teaching the immune system to attack high-risk acute lymphoblastic leukemia (ALL) and turning it into an ally against leukemia in children and adolescents is possible. This is the conclusion of the AIEOP-BFM ALL 2017 study, a long and complex international clinical trial in which two cycles of...

AUSTIN, Texas — Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of new data in Blood Neoplasia, validating the prognostic and predictive value of Signatera in patients with both newly diagnosed and relapsed/refractory (R/R) lymphoma. PET/CT scans serve as the standard tool for assessing treatment...

LINKÖPING, Sweden – AMRA Medical is pleased to announce the publication of new research in Neurology demonstrating the potential of quantitative whole-body MRI to measure disease progression in Spinal and Bulbar Muscular Atrophy (SBMA), a rare, progressive neuromuscular disease. The research was also selected for the cover of the issue, providing...